Transforming growth factor ß (TGF ß) is a multifunctional growth regulator with diverse biological effects, including promotion and inhibition of fibroblastic and epithelial cell growth, respectively (1, 2), chemotaxis of dermal fibroblasts and monocytes (3, 4), facilitation of extracellular matrix remodeling by fibroblastic cells (5-7), and effects on proliferation and function of T and B lymphocytes (8-10). These cellular responses appear pertinent to development and/or maintenance ofthe synovial panmus in inflammatory arthritis. Furthermore, subcutaneous injection of purified TGFP into newborn mice results in a multicellular response over 48-72 h (11), which is histologically similar to the synovial panmus seen in rheumatoid arthritis (RA). These findings led us to examine synovial effusions for the presence of TGFß.
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BRIEF DEFINITIVE REPORT 5A medium supplemented with 10% FCS were prepared in 35-mm culture dishes . Upper layers of 0.4% agar in McCoy's 5A medium contained 10% FCS, 7 .5 x 10j cells, and the synovial fluid to be tested . The number of colonies >50 gm was quantitated after 7 d using an image analyzer (Omnicon FAS III ; Bausch & Lomb, Inc., Rochester, NY) . Soft agar assays were also performed in 24-well plates with NRK-49F indicator cells in a highly sensitive serum-free assay (>2 pg TGF0) (14) . Supplemental growth factors (see Fig.  2 legend), human high density lipoprotein (HDL), retinoic acid, and the samples to be tested were added simultaneously to a 0.3 ml overlayer of basal medium immediately after plating the cells. To evaluate the ability of specific antisera to block colony formation induced by TGF-p or acid-treated synovial fluid, 20 ltg of normal rabbit IgG or 20 ug IgG isolated from antisera against TGF-P (15) were added to the upper medium layer (simultaneously with other factors) . After 10 d incubation at 37°C, the colonies were fixed and stained with 10% formaldehyde/0 .01 % crystal violet, counted with the aid of a dissecting microscope, and the efficiency of colony formation was expressed as the percentage of plated cells forming colonies >50 ltm in diameter.
Acid Activation of Latent TGF-/3 . TGF-P is known to exist in two forms, an active form that interacts directly with cell surface receptors and a less well characterized "latent" form(s) that can be activated by acidification, proteolysis, and other biochemical methods (12) . Six randomly selected fluids were acid treated by dialysis of a 1 .0-ml aliquot in 1 M acetic acid (pH 3 .6) for 18 h at 25°C . The resultant precipitate was removed by centrifugation for 5 min at 12,000 g. The supernatant was then dialyzed against 10 mM acetic acid and assayed for TGF-0 . Equivalent aliquots of 10 mM acetic acid were shown not to affect the assays .
Results
A dose-response curve for the radioreceptor competition assay that was used to quantitate TGF0 activity in untreated and acid-activated synovial effusions is shown in Fig. 1 . In all synovial fluid samples examined, dose-response curves were observed that were similar to that seen when purified unlabeled TGF0 was added as competitor. Thus, despite their complex composition, the synovial fluids appear to have capacity to compete directly for receptor binding, similarly to purified TGF-0.
The mean levels of active TGF-P in untreated synovial fluids (Table I) were 10 .1 ng/ml for RA fluids and 3.8 ng/ml for osteoarthritis fluids, a statistically significant difference (p < 0.005). Two gout fluids showed a mean level of 8 .0 ng/ml, and a noninflammatory fluid (white blood cells, <200) obtained from a patient with avascu1ar necrosis showed no TGF0 activity detectable by the radioreceptor assay (<1 Competition of untreated and acid-activated synovial fluids and purified TGFp in a receptor binding assay performed with cultured AKR2B fibroblasts. Percent inhibition represents the reduction in specific binding, observed when cells were incubated for 2 h at 25°C, in the presence of 125 ITGF p (0 .25 ng/ml) and the indicated amounts (ng) of unlabeled TGF0 (") or aliquots (g1) of synovial fluid preparations . All illustrated synovial fluids were from patients with diagnoses of RA . One fluid, RA#1 (ACID), was also assayed after acid activation as described in o Mean Levels of TGF-0 (ng/ml) in Synovial Effusions by Radioreceptor Assay
Transient acidification before assay (Materials and Methods) . 1 p < 0 .005 between these two groups . 9 Determined by NRK-49F colony formation assay . ng/ml) . Acid activation resulted in increased TGF-0 activity in all six fluids tested, indicating the likelihood of a latent TGF ß pool .
To confirm the presence of the TGF-ß-like activity using an additional assay, five fluids were examined for the capacity to promote soft-agar colony formation of AKR 2B and NRK-49F fibroblasts . Each of the fluids examined was found to promote softagar colony formation by the indicator cell lines in a dose-dependent manner (data not shown). Colony formation of NRK-49F cells induced by each of five fluids examined required exogenous epidermal growth factor in this serum-free assay, as has been previously described for TGF-0 (14) . The use of this extremely sensitive assay enabled recognition of 0.8 ng/ml TGF-ß for the acid activated avascu1ar necrosis fluid shown in Table I .
The TGF-0 activity present in acid-activated synovial fluid, at a dose equivalent to 8 pg TGF-ß, was completely abolished when 20 gg of anti TGF-ß IgG, but not an equivalent amount of normal rabbit IgG, was included in the assay (Fig . 2) . Three synovial fluids from RA patients examined in this manner gave similar results .
Since TGFP is normally stored in platelets and released upon platelet lysis, it appeared of value to examine whether any portion of the observed TGF ß activity in routinely collected cell-free fluids may have been derived from in vitro platelet lysis . Therefore, replicate aliquots of two randomly chosen synovial fluids were pre- Soft-agar colony formation by acid activated and untreated synovial fluids and inhibition by antibody against TGFp . NRK-49F cells were plated in soft-agar in a serumfree medium supplemented with insulin (10 Wg/ml), transferrin (5 jig/ml), HDL (100 jig/ ml), retinoic acid (100 ng/ml), and epidermal growth factor (50 ng/ml) and additions were made as shown in the Figure . pared under routine and more stringent conditions designed to eliminate platelet contamination (see Materials and Methods). There was essentially no difference in the amount of TGF ß detected after either method of preparation for the two fluids examined (Table II) .
Discussion The presence of TGF-ß-like activity in inflammatory synovial fluids suggests that this multifunctional mediator may participate in the initiation or maintenance of synovitis, or may appear as the consequence of a tissue response to the presence of other cytokines . It is possible that the competition observed in the radioreceptor assay may result in part from TGF ß binding proteins present in whole synovial fluids. However, the demonstration of activity in soft-agar colony formation, of immunological neutralization of biological activity, and activation of latent forms, would strongly suggest that TGF-ß activity is present in synovial fluid .
Several cellular responses known to be mediated by TGF p might play a role in the development and/or maintenance of inflammatory synovitis, including : (a) the capacity to stimulate chemotaxis and, therefore, local "accumulation" of fibroblasts (3) ; (b) promotion of collagen, proteoglycan, and fibronectin production by fibroblastic cells (5-7), which could contribute to elevated levels of atypical isoforms of fibronectin that have been reported to accumulate in RA joint fluids (16, 17) ; (c) chemotaxis ofmonocytes (4); and (d) antiproliferative or immunosuppressive effects on T cells (8) (9) (10) , which may account in part for the reduced in vitro response of isolated synovial fluid lymphocytes to proliferation stimuli (18) .
The TGFß found in synovial fluid may be delivered from T lymphocytes, B lymphocytes, and/or activated macrophages, all of which have been shown to produce TGF-ß (8, 9, 19) , platelets lysed at sites of microvascular injury, and synovial cells themselves (20) . Activation of latent TGF R-like activity can be effected by proteases such as plasmin and cathepsin D (12) . If present in the synovial panmus, such "activating" proteases could increase levels of active TGF ß locally. Thus, alterations in the levels of such proteases and/or their inhibitors in the synovial panmus could act in concert with latent TGF0 production by endogenous or infiltrating cell types in sustaining the complex cellular activities observed in this lesion. Further investigation into the role of TGF ß in the development of synovitis may provide important clues to the etiopathogenesis of the inflammatory arthritides.
Summary
We have evaluated the possible involvement of TGF ß in rheumatoid arthritis by assay of 16 cell-free synovial fluids for the presence of its active and "latent" forms. 
